The year 2021 will mark 100 years since the discovery of insulin. Insulin, the first medication
to be discovered for diabetes, is still the safest and most potent glucose-lowering therapy …

The design of carriers for insulin delivery has recently attracted major research attentions in
the biomedical field. In general, the release of drug from polymers is driven via a variety of …

Individuals with type 1 and advanced type 2 diabetes require daily insulin therapy to
maintain blood glucose levels in normoglycemic ranges to prevent associated morbidity and …

Neurotrophic keratopathy (NK) is a degenerative corneal disease with a loss of corneal
sensitivity and impairment of corneal healing. Low dose insulin eyedrops have been shown …

Insulin is recognized as a crucial weapon in managing diabetes. Subcutaneous (sc)
injections are the traditional approach for insulin administration, which usually have many …

In people with diabetes, the most efficient therapeutic option available to reduce
hyperglycemia continues to be insulin even though they experience numerous challenges …

Efforts directed toward restoring normal metabolic levels by mimicking the physiological
insulin secretion, thereby ensuring safety, efficacy, minimal invasiveness and conveniences …

Background Advances in pump technology and the availability of insulin analogs, as well as
the results of the Diabetes Control and Complications Trial (DCCT), which established the …

Diabetes mellitus is one of the fastest-growing lifestyle disorders in the world. While
numerous regimes have been developed to manage diabetes, there continue to be high …

Insulin pen technology has significantly advanced since the first pen was launched by Novo
Nordisk in 1985 and now 'smart'connected pens are available, which can record the timing …